Scrutinizer Report of the Annual General Meeting held on 30th August, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem Limited held its Annual General Meeting on 30th August 2025 at 4:02 PM via video conferencing. Seven resolutions were put to vote through remote e-voting, which ran from 27th to 29th August 2025. All seven resolutions were passed with 100% of valid votes in favour and zero votes against. Resolutions 1, 2, 3 and 7 received 6,124,300 valid votes each, while resolutions 4, 5 and 6 — which appear to be related-party resolutions — received 3,724,700 valid votes in favour after promoter group votes (2,399,600) were excluded as invalid due to their interest in those items. The company is listed on the BSE SME platform (Scrip Code: 543594). The report was signed by scrutinizer Jay Pandya and countersigned by Chairperson Dipna Shah.
The unanimous approval of all seven resolutions indicates smooth shareholder consensus with no dissent, which is a neutral-to-positive signal for retail investors. The exclusion of promoter votes on resolutions 4, 5 and 6 is standard procedure for related-party items and confirms proper corporate governance. No material negative signals for shareholders.